What is the latest BI stock price?
The latest stored price for BI is Rs 60.70 as of 2026-07-21.
gimli
BI stock AI analysis
BI Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
BILCARE LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available BI price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹60.70
1W return
-4.98%
1M return
+5.16%
3M return
-0.16%
6M return
n/a
1Y return
n/a
Market cap
₹n/a
PE
n/a
PB
n/a
ROE
n/a
ROCE
n/a
RSI
47.07
Turnover
₹0.04 cr
Why it can matter in screens
- Momentum: BI is below 50DMA, below 200DMA; RSI is 47.07.
- Returns: 1D -2.13%, 1W -4.98%, 1M +5.16%, 3M -0.16%, 1Y n/a.
- Trend levels: 52W high ₹72.10, 52W low ₹56.18, off high -15.81%.
- Liquidity: latest turnover is ₹0.04 cr; volume vs 20D is +0.78%.
- Valuation/profitability: PE n/a, PB n/a, ROE n/a, ROCE n/a.
- Growth: 3Y sales CAGR n/a, 3Y profit CAGR n/a.
Quick Answers
Is BI above its 50DMA and 200DMA?
BI is below 50DMA, below 200DMA. The latest 50DMA is 61.88 and the latest 200DMA is n/a.
What are BI PE, ROE and ROCE?
BI has PE n/a, ROE n/a, and ROCE n/a in Gimli's latest available snapshot.
How has BI performed recently?
BI has returned +5.16% over 1 month, -0.16% over 3 months, and n/a over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
No recent data available.
Annual income statement
No recent data available.
Balance sheet
No recent data available.
Cash flow
No recent data available.
Shareholding Trend
No recent data available.
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 470,725.53 cr | 40.938102 | +14.71% | +15.93% |
| DIVISLAB | DIVI S LABORATORIES LTD | 194,588.48 cr | 75.774332 | +16.19% | +9.60% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 170,600.17 cr | 78.872017 | +17.18% | +43.04% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 128,349.41 cr | 65.537894 | +21.03% | +23.05% |
| CIPLA | CIPLA LTD | 115,717.42 cr | 29.815932 | +11.79% | -2.81% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 115,022.61 cr | 22.938459 | +17.93% | +17.85% |
| LUPIN | LUPIN LIMITED | 114,980.65 cr | 21.532280 | +26.83% | +30.91% |
| MAXHEALTH | MAX HEALTHCARE INS LTD | 107,095.75 cr | 74.247785 | +14.33% | -9.67% |
Try these prompts
- Analyze BILCARE. with valuation, momentum and industry peers
- Compare BI with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare BI with other Healthcare stocks
Data snapshot: 2026-07-21. Not investment advice.